Financhill
Sell
44

DBVT Quote, Financials, Valuation and Earnings

Last price:
$8.39
Seasonality move :
2.77%
Day range:
$8.25 - $8.68
52-week range:
$2.20 - $12.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
79.50x
Volume:
47.3K
Avg. volume:
101.9K
1-year change:
45.75%
Market cap:
$228.4M
Revenue:
--
EPS (TTM):
-$5.70
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $101.6M $70.3M $75.5M $60.2M $89.3M
Selling, General & Admin $31M $21.7M $17.6M $22.8M $23.9M
Other Inc / (Exp) -$23.6M $920K -- -- --
Operating Expenses $135.3M $99.5M $96.6M $76.4M $116.6M
Operating Income -$135.3M -$99.5M -$96.6M -$76.4M -$116.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$159.6M -$98.2M -$96.2M -$72.7M -$113.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$10K -$381K $70K $7K $55K
Net Income to Company -$159.6M -$97.8M -$96.3M -$72.7M -$113.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$159.6M -$97.8M -$96.3M -$72.7M -$113.9M
 
Basic EPS (Cont. Ops) -$14.75 -$8.90 -$6.20 -$3.80 -$5.85
Diluted EPS (Cont. Ops) -$14.75 -$8.90 -$6.20 -$3.80 -$5.85
Weighted Average Basic Share $10.8M $11M $15.5M $19M $19.4M
Weighted Average Diluted Share $10.8M $11M $15.5M $19M $19.4M
 
EBITDA -$121.4M -$86.3M -$83.5M -$67.3M -$109M
EBIT -$135.3M -$99.5M -$96.6M -$76.4M -$116.6M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$135.3M -$99.5M -$96.6M -$76.4M -$116.6M
Operating Income (Adjusted) -$135.3M -$99.5M -$96.6M -$76.4M -$116.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $22.2M $12.2M $16M $21.4M $21.5M
Selling, General & Admin $6.8M $4.2M $5.2M $6.2M $4.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $29.6M $16.8M $21.2M $28.6M $26.6M
Operating Income -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$29.4M -$16.6M -$20.6M -$27.3M -$27.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $30K $87K -- $48K --
Net Income to Company -$29.4M -$16.7M -$20.6M -$27.3M -$27.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$29.4M -$16.7M -$20.6M -$27.3M -$27.1M
 
Basic EPS (Cont. Ops) -$2.70 -$1.50 -$1.10 -$1.40 -$1.30
Diluted EPS (Cont. Ops) -$2.70 -$1.50 -$1.10 -$1.40 -$1.30
Weighted Average Basic Share $11M $11M $18.8M $19.2M $20.5M
Weighted Average Diluted Share $11M $11M $18.8M $19.2M $20.5M
 
EBITDA -$26M -$13.8M -$19.1M -$26.2M -$25M
EBIT -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
Operating Income (Adjusted) -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $96.2M $60.4M $79.4M $65.6M $89.4M
Selling, General & Admin $22.2M $18.7M $18.7M $23.7M $22M
Other Inc / (Exp) -$23.6M -- -- -- --
Operating Expenses $123.7M $86.7M $101M $83.8M $114.7M
Operating Income -$123.7M -$86.7M -$101M -$83.8M -$114.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$148.1M -$85.4M -$100.1M -$79.5M -$113.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $20K -$324K -$17K $55K $7K
Net Income to Company -$148.1M -$85.1M -$100.1M -$79.5M -$113.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$148.1M -$85.1M -$100.1M -$79.5M -$113.7M
 
Basic EPS (Cont. Ops) -$13.50 -$7.75 -$6.00 -$4.10 -$5.70
Diluted EPS (Cont. Ops) -$13.50 -$7.75 -$6.00 -$4.10 -$5.70
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$99M -$70.4M -$82.8M -$74.4M -$107.9M
EBIT -$123.7M -$86.7M -$101M -$83.8M -$114.7M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$123.7M -$86.7M -$101M -$83.8M -$114.7M
Operating Income (Adjusted) -$123.7M -$86.7M -$101M -$83.8M -$114.7M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $22.2M $12.2M $16M $21.4M $21.5M
Selling, General & Admin $6.8M $4.2M $5.2M $6.2M $4.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $29.6M $16.8M $21.2M $28.6M $26.6M
Operating Income -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$29.4M -$16.6M -$20.6M -$27.3M -$27.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $30K $87K -- $48K --
Net Income to Company -$29.4M -$16.7M -$20.6M -$27.3M -$27.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$29.4M -$16.7M -$20.6M -$27.3M -$27.1M
 
Basic EPS (Cont. Ops) -$2.70 -$1.50 -$1.10 -$1.40 -$1.30
Diluted EPS (Cont. Ops) -$2.70 -$1.50 -$1.10 -$1.40 -$1.30
Weighted Average Basic Share $11M $11M $18.8M $19.2M $20.5M
Weighted Average Diluted Share $11M $11M $18.8M $19.2M $20.5M
 
EBITDA -$26M -$13.8M -$19.1M -$26.2M -$25M
EBIT -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
Operating Income (Adjusted) -$29.6M -$16.8M -$21.2M -$28.6M -$26.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $196.4M $77.3M $209.2M $141.4M $32.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.2M -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $3.2M $4.1M $2.7M $2.1M $1.5M
Other Current Assets $1K $1K $1K -$1K --
Total Current Assets $207.4M $114.4M $223.1M $158.9M $44.4M
 
Property Plant And Equipment $34.9M $25.5M $17.6M $17.9M $16.8M
Long-Term Investments $2.7M $2.7M $1.8M -- $4.3M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $4.3M $4M $3.7M $6.1M --
Total Assets $272.2M $146.7M $246.5M $183M $65.7M
 
Accounts Payable $20.3M $11.4M $14.5M $23.3M $22M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $1.7M $1.8M $1.1M $883K $846K
Current Portion Of Capital Lease Obligations $3.7M $3M $1.9M $1.1M $654K
Other Current Liabilities $21.7M $10.8M $9.8M $11.8M $7.4M
Total Current Liabilities $52.7M $31.4M $29.5M $37.3M $31.1M
 
Long-Term Debt $543K -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $66.8M $47.4M $52.1M $42.8M $38.3M
 
Common Stock $6.5M $6.5M $10.7M $11M $11.7M
Other Common Equity Adj $484K $519K $781K $742K $905K
Common Equity $205.5M $99.3M $194.5M $140.2M $27.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $205.5M $99.3M $194.5M $140.2M $27.4M
 
Total Liabilities and Equity $272.2M $146.7M $246.5M $183M $65.7M
Cash and Short Terms $196.4M $77.3M $209.2M $141.4M $32.5M
Total Debt -- -- -- -- --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $152.5M $74.1M $192.3M $101.5M $13M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- $3.4M $2.4M $1.7M $3.9M
Other Current Assets $7.4M $1K $1K $1K -$1K
Total Current Assets $159.8M $90.4M $210.2M $119.6M $29.1M
 
Property Plant And Equipment $30.7M $20.6M $16.9M $19.5M $16.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $30.9M $6.6M $5.8M $6.8M $5M
Total Assets $221.4M $117.6M $232.9M $145.9M $50.6M
 
Accounts Payable $17.2M $11.4M $19.9M $18.1M $34.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $1.2M $1.1M $297K $214K $272K
Current Portion Of Capital Lease Obligations $3.3M $2M $1.9M $232K $709K
Other Current Liabilities $13.5M $7.5M $4.1M $3.2M $81K
Total Current Liabilities $38.8M $26M $32.8M $26.5M $40.4M
 
Long-Term Debt $350K -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $52.2M $35.5M $53.8M $34.2M $47.7M
 
Common Stock $6.5M $6.5M $10.7M $11M $11.7M
Other Common Equity Adj $399K $543K $698K $683K $1M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $169.2M $82.1M $179.1M $111.7M $2.9M
 
Total Liabilities and Equity $221.4M $117.6M $232.9M $145.9M $50.6M
Cash and Short Terms $152.5M $74.1M $192.3M $101.5M $13M
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$159.6M -$97.8M -$96.3M -$72.7M -$113.9M
Depreciation & Amoritzation $10.5M $8.4M $13.2M -$14M -$925K
Stock-Based Compensation -$1.1M $3.1M $5M $6M $4.6M
Change in Accounts Receivable -$2.1M $2.2M -- -- --
Change in Inventories $2.3M -- -- -- --
Cash From Operations -$165.6M -$108.2M -$55.7M -$79.7M -$104.5M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.9M -$433K -$100K -$808K -$757K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$563K -- -- -$154K -$47K
Other Financing Activities -$338K -$704K -$474K -- --
Cash From Financing $149.5M $274K $194.1M $6.8M $587K
 
Beginning Cash (CF) $193.3M $196.4M $77.3M $209.2M $141.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$18.9M -$108.4M $138.4M -$73.7M -$104.6M
Ending Cash (CF) $196.4M $77.3M $209.2M $141.4M $32.5M
 
Levered Free Cash Flow -$168.4M -$109.2M -$56.4M -$80.3M -$106.8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$29.4M -$16.7M -$20.6M -$27.3M -$27.1M
Depreciation & Amoritzation $1.5M -$599K -$228K $53K $952K
Stock-Based Compensation $1.4M $1.4M $1.6M $2M $1.7M
Change in Accounts Receivable $2.1M -- -- -- --
Change in Inventories -- -- -- -$1.3M -$4.3M
Cash From Operations -$36.2M -$1.5M -$20.8M -$34.7M -$19.7M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$185K $11K $42K -$2.1M -$375K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$180K -$169K -- -- --
Cash From Financing $440K -$129K -$14K -$62K $45K
 
Beginning Cash (CF) $196.4M $77.3M $209.2M $141.4M $32.5M
Foreign Exchange Rate Adjustment -$7.9M -$1.6M $3.9M -$3M $504K
Additions / Reductions -$35.9M -$1.6M -$20.8M -$36.9M -$20M
Ending Cash (CF) $152.5M $74.1M $192.3M $101.5M $13M
 
Levered Free Cash Flow -$36.4M -$1.6M -$21M -$36M -$19.7M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$148.1M -$85.1M -$100.1M -$79.5M -$113.7M
Depreciation & Amoritzation $10.4M $6.3M $13.5M -$13.7M -$26K
Stock-Based Compensation -$2.8M $3.1M $5.3M $6.3M $4.4M
Change in Accounts Receivable $31K -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$152.1M -$73.5M -$75M -$93.5M -$89.5M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.1M -$237K -$69K -$3M $1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$518K -$693K -- -- --
Cash From Financing -$623K -$295K $194.2M $6.7M $694K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$154.9M -$74.1M $119.1M -$89.8M -$87.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$154.2M -$74.4M -$75.8M -$95.4M -$90.5M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$29.4M -$16.7M -$20.6M -$27.3M -$27.1M
Depreciation & Amoritzation $1.5M -$599K -$228K $53K $952K
Stock-Based Compensation $1.4M $1.4M $1.6M $2M $1.7M
Change in Accounts Receivable $2.1M -- -- -- --
Change in Inventories -- -- -- -$1.3M -$4.3M
Cash From Operations -$36.2M -$1.5M -$20.8M -$34.7M -$19.7M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$185K $11K $42K -$2.1M -$375K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$180K -$169K -- -- --
Cash From Financing $440K -$129K -$14K -$62K $45K
 
Beginning Cash (CF) $196.4M $77.3M $209.2M $141.4M $32.5M
Foreign Exchange Rate Adjustment -$7.9M -$1.6M $3.9M -$3M $504K
Additions / Reductions -$35.9M -$1.6M -$20.8M -$36.9M -$20M
Ending Cash (CF) $152.5M $74.1M $192.3M $101.5M $13M
 
Levered Free Cash Flow -$36.4M -$1.6M -$21M -$36M -$19.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock